A detailed history of Victory Capital Management Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 1,258,208 shares of FOLD stock, worth $12.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,258,208
Previous 2,273,959 44.67%
Holding current value
$12.4 Million
Previous $22.6 Million 40.43%
% of portfolio
0.01%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$9.55 - $12.09 $9.7 Million - $12.3 Million
-1,015,751 Reduced 44.67%
1,258,208 $13.4 Million
Q2 2024

Aug 05, 2024

BUY
$9.04 - $11.75 $3.12 Million - $4.06 Million
345,117 Added 17.89%
2,273,959 $22.6 Million
Q1 2024

May 03, 2024

BUY
$11.43 - $14.24 $2.01 Million - $2.51 Million
176,155 Added 10.05%
1,928,842 $22.7 Million
Q4 2023

Feb 05, 2024

SELL
$9.97 - $14.52 $11.9 Million - $17.4 Million
-1,196,519 Reduced 40.57%
1,752,687 $24.9 Million
Q3 2023

Nov 06, 2023

BUY
$11.78 - $13.86 $27.7 Million - $32.6 Million
2,350,262 Added 392.4%
2,949,206 $35.9 Million
Q2 2023

Jul 27, 2023

SELL
$10.72 - $13.3 $14.1 Million - $17.4 Million
-1,311,824 Reduced 68.65%
598,944 $7.52 Million
Q1 2023

May 02, 2023

BUY
$10.91 - $13.54 $18.9 Million - $23.4 Million
1,728,159 Added 946.37%
1,910,768 $21.2 Million
Q4 2022

Feb 10, 2023

BUY
$9.89 - $12.7 $2,739 - $3,517
277 Added 0.15%
182,609 $2.23 Million
Q4 2022

Feb 09, 2023

BUY
$9.89 - $12.7 $401,514 - $515,594
40,598 Added 28.64%
182,332 $2.23 Million
Q3 2022

Nov 02, 2022

BUY
$9.82 - $12.75 $536,014 - $695,946
54,584 Added 62.63%
141,734 $1.48 Million
Q2 2022

Aug 01, 2022

BUY
$6.23 - $11.12 $335,684 - $599,167
53,882 Added 161.96%
87,150 $936,000
Q1 2022

May 04, 2022

SELL
$7.89 - $12.48 $6,154 - $9,734
-780 Reduced 2.29%
33,268 $236,000
Q4 2021

Feb 07, 2022

BUY
$9.82 - $12.44 $618 - $783
63 Added 0.19%
34,048 $393,000
Q3 2021

Nov 02, 2021

SELL
$8.74 - $11.84 $10,767 - $14,586
-1,232 Reduced 3.5%
33,985 $325,000
Q2 2021

Aug 03, 2021

BUY
$8.71 - $10.72 $679 - $836
78 Added 0.22%
35,217 $339,000
Q1 2021

May 04, 2021

SELL
$9.2 - $23.86 $29 Million - $75.3 Million
-3,154,913 Reduced 98.9%
35,139 $347,000
Q4 2020

Feb 01, 2021

SELL
$13.47 - $24.89 $8.56 Million - $15.8 Million
-635,449 Reduced 16.61%
3,190,052 $73.7 Million
Q3 2020

Nov 09, 2020

BUY
$12.89 - $15.89 $4.1 Million - $5.05 Million
317,779 Added 9.06%
3,825,501 $54 Million
Q2 2020

Aug 07, 2020

SELL
$8.86 - $15.69 $4.41 Million - $7.81 Million
-497,762 Reduced 12.43%
3,507,722 $52.9 Million
Q1 2020

May 04, 2020

SELL
$6.63 - $11.16 $117,297 - $197,442
-17,692 Reduced 0.44%
4,005,484 $37 Million
Q4 2019

Feb 06, 2020

SELL
$7.48 - $10.75 $326,599 - $469,377
-43,663 Reduced 1.07%
4,023,176 $39.2 Million
Q4 2019

Feb 04, 2020

BUY
$7.48 - $10.75 $2.98 Million - $4.29 Million
398,955 Added 10.88%
4,066,839 $36 Million
Q3 2019

Nov 12, 2019

BUY
$8.02 - $13.25 $123,708 - $204,381
15,425 Added 0.42%
3,667,884 $29.4 Million
Q2 2019

Aug 15, 2019

BUY
$10.96 - $14.4 $6.01 Million - $7.9 Million
548,730 Added 17.68%
3,652,459 $45.6 Million
Q1 2019

May 03, 2019

SELL
$10.04 - $13.92 $453,004 - $628,070
-45,120 Reduced 1.43%
3,103,729 $42.2 Million
Q4 2018

Feb 05, 2019

SELL
$8.38 - $13.44 $4.97 Million - $7.97 Million
-592,805 Reduced 15.84%
3,148,849 $30.2 Million
Q3 2018

Nov 01, 2018

BUY
$11.6 - $16.54 $1.57 Million - $2.24 Million
135,615 Added 3.76%
3,741,654 $45.2 Million
Q2 2018

Aug 02, 2018

BUY
$13.13 - $17.09 $7.23 Million - $9.41 Million
550,740 Added 18.03%
3,606,039 $56.3 Million
Q1 2018

May 04, 2018

BUY
$13.76 - $17.12 $5.65 Million - $7.03 Million
410,375 Added 15.52%
3,055,299 $46 Million
Q4 2017

Feb 01, 2018

BUY
$12.51 - $16.24 $1.9 Million - $2.46 Million
151,755 Added 6.09%
2,644,924 $38.1 Million
Q3 2017

Oct 27, 2017

SELL
$11.74 - $15.78 $22 Million - $29.6 Million
-1,876,410 Reduced 42.94%
2,493,169 $37.6 Million
Q2 2017

Aug 07, 2017

BUY
N/A
4,369,579
4,369,579 $44 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.77B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.